05 February, 2025 | Wednesday
BioPharma Boardroom
UCB and Ariceum Therapeutics Partner for Immune-Related Disease and Cancer Treatment Research

UCB's expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum's discovery of t...

May 11, 2023 | Thursday | News
OliX Pharmaceuticals and DynamiCure Partner for RNA-Based ADC Immunotherapy at Korea-US Business Forum

OliX participated in the ‘Korea-US Digital·BioHealth Business Forum’ hosted by the South Korean Ministry of Health and Welfare and Kor...

May 11, 2023 | Thursday | News
Bayer and Bicycle Therapeutics Partner for Targeted Radionuclide Therapies in Oncology

Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the ...

May 11, 2023 | Thursday | News
Lavita AI Raises $5M to Launch Patient-Driven Health Info Marketplace for Life Sciences

-Lavita AI, a next generation AI+Web3 healthcare platform, announced today it has closed a $5M seed financing round, led by Camford Capital, and angel inve...

May 11, 2023 | Thursday | News

Partner Content

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
  View poll results   More polls
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
BioPharma Boardroom

About Us Media Pack Contact Us Privacy Policy

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close